Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding.
Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding.
复制标题
人心脏β-肾上腺素能受体:通过直接放射性配体结合描绘的亚型异质性。
DOI:
10.1016/0024-3205(83)90796-8
复制
发表时间:
1983
期刊:
影响因子:
6.1
通讯作者:
Lefkowitz,RJ
中科院分区:
文献类型:
--
作者:
Stiles,GL;Taylor,S;Lefkowitz,RJ
Human myocardial beta-adrenergic receptors were directly identified and characterized using the high affinity antagonist radioligand [125I] iodocyanopindolol. Beta1and beta2adrenergic receptors were found to coexist in both the left ventricle and right atrium. The relative proportions of the two receptor subtypes were determined by the use of competition radioligand binding and computer modelling techniques employing the subtype selective agents atenolol (beta1selective) and zinterol (beta2selective). The left ventricle contains 86 ± 1% beta1and 14 ± 1% beta2adrenergic receptors while the right atrium contains 74 ± 6% beta1and 26 ± 6% beta2adrenergic receptors. The direct demonstration of beta2adrenergic receptors in the human heart, with a higher proportion in the right atrium agrees with pharmacologic data and supports the notion that chronotropic effects of adrenergic agonists in man may be mediated by both beta1and beta2adrenergic receptors.